Copyright Reports & Markets. All rights reserved.

Global Irbesartan Amlodipine Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Irbesartan Amlodipine Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Original Drug
    • 1.3.3 Generic Drug
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Irbesartan Amlodipine Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hypertension
    • 1.4.3 Myocardial infarction
    • 1.4.4 Others
  • 1.5 Global Irbesartan Amlodipine Tablets Market Size & Forecast
    • 1.5.1 Global Irbesartan Amlodipine Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Irbesartan Amlodipine Tablets Sales Quantity (2021-2032)
    • 1.5.3 Global Irbesartan Amlodipine Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Iluamix
    • 2.1.1 Iluamix Details
    • 2.1.2 Iluamix Major Business
    • 2.1.3 Iluamix Irbesartan Amlodipine Tablets Product and Services
    • 2.1.4 Iluamix Irbesartan Amlodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Iluamix Recent Developments/Updates
  • 2.2 Sanofi
    • 2.2.1 Sanofi Details
    • 2.2.2 Sanofi Major Business
    • 2.2.3 Sanofi Irbesartan Amlodipine Tablets Product and Services
    • 2.2.4 Sanofi Irbesartan Amlodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Sanofi Recent Developments/Updates
  • 2.3 Sumitomo Pharma
    • 2.3.1 Sumitomo Pharma Details
    • 2.3.2 Sumitomo Pharma Major Business
    • 2.3.3 Sumitomo Pharma Irbesartan Amlodipine Tablets Product and Services
    • 2.3.4 Sumitomo Pharma Irbesartan Amlodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sumitomo Pharma Recent Developments/Updates
  • 2.4 Teva Pharmaceutical
    • 2.4.1 Teva Pharmaceutical Details
    • 2.4.2 Teva Pharmaceutical Major Business
    • 2.4.3 Teva Pharmaceutical Irbesartan Amlodipine Tablets Product and Services
    • 2.4.4 Teva Pharmaceutical Irbesartan Amlodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Teva Pharmaceutical Recent Developments/Updates
  • 2.5 Novartis
    • 2.5.1 Novartis Details
    • 2.5.2 Novartis Major Business
    • 2.5.3 Novartis Irbesartan Amlodipine Tablets Product and Services
    • 2.5.4 Novartis Irbesartan Amlodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Novartis Recent Developments/Updates
  • 2.6 Shionogi
    • 2.6.1 Shionogi Details
    • 2.6.2 Shionogi Major Business
    • 2.6.3 Shionogi Irbesartan Amlodipine Tablets Product and Services
    • 2.6.4 Shionogi Irbesartan Amlodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Shionogi Recent Developments/Updates
  • 2.7 Hanall
    • 2.7.1 Hanall Details
    • 2.7.2 Hanall Major Business
    • 2.7.3 Hanall Irbesartan Amlodipine Tablets Product and Services
    • 2.7.4 Hanall Irbesartan Amlodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Hanall Recent Developments/Updates
  • 2.8 Shilpex Pharmysis
    • 2.8.1 Shilpex Pharmysis Details
    • 2.8.2 Shilpex Pharmysis Major Business
    • 2.8.3 Shilpex Pharmysis Irbesartan Amlodipine Tablets Product and Services
    • 2.8.4 Shilpex Pharmysis Irbesartan Amlodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Shilpex Pharmysis Recent Developments/Updates
  • 2.9 Garden Bio-chemical High-tech
    • 2.9.1 Garden Bio-chemical High-tech Details
    • 2.9.2 Garden Bio-chemical High-tech Major Business
    • 2.9.3 Garden Bio-chemical High-tech Irbesartan Amlodipine Tablets Product and Services
    • 2.9.4 Garden Bio-chemical High-tech Irbesartan Amlodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Garden Bio-chemical High-tech Recent Developments/Updates
  • 2.10 Huahai Pharmaceutical
    • 2.10.1 Huahai Pharmaceutical Details
    • 2.10.2 Huahai Pharmaceutical Major Business
    • 2.10.3 Huahai Pharmaceutical Irbesartan Amlodipine Tablets Product and Services
    • 2.10.4 Huahai Pharmaceutical Irbesartan Amlodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Huahai Pharmaceutical Recent Developments/Updates
  • 2.11 Shimei Pharmaceutica
    • 2.11.1 Shimei Pharmaceutica Details
    • 2.11.2 Shimei Pharmaceutica Major Business
    • 2.11.3 Shimei Pharmaceutica Irbesartan Amlodipine Tablets Product and Services
    • 2.11.4 Shimei Pharmaceutica Irbesartan Amlodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Shimei Pharmaceutica Recent Developments/Updates
  • 2.12 Kangzhe Pharmaceutica
    • 2.12.1 Kangzhe Pharmaceutica Details
    • 2.12.2 Kangzhe Pharmaceutica Major Business
    • 2.12.3 Kangzhe Pharmaceutica Irbesartan Amlodipine Tablets Product and Services
    • 2.12.4 Kangzhe Pharmaceutica Irbesartan Amlodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Kangzhe Pharmaceutica Recent Developments/Updates

3 Competitive Environment: Irbesartan Amlodipine Tablets by Manufacturer

  • 3.1 Global Irbesartan Amlodipine Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Irbesartan Amlodipine Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Irbesartan Amlodipine Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Irbesartan Amlodipine Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Irbesartan Amlodipine Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Irbesartan Amlodipine Tablets Manufacturer Market Share in 2025
  • 3.5 Irbesartan Amlodipine Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Irbesartan Amlodipine Tablets Market: Region Footprint
    • 3.5.2 Irbesartan Amlodipine Tablets Market: Company Product Type Footprint
    • 3.5.3 Irbesartan Amlodipine Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Irbesartan Amlodipine Tablets Market Size by Region
    • 4.1.1 Global Irbesartan Amlodipine Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Irbesartan Amlodipine Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Irbesartan Amlodipine Tablets Average Price by Region (2021-2032)
  • 4.2 North America Irbesartan Amlodipine Tablets Consumption Value (2021-2032)
  • 4.3 Europe Irbesartan Amlodipine Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Irbesartan Amlodipine Tablets Consumption Value (2021-2032)
  • 4.5 South America Irbesartan Amlodipine Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Irbesartan Amlodipine Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Irbesartan Amlodipine Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Irbesartan Amlodipine Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Irbesartan Amlodipine Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Irbesartan Amlodipine Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Irbesartan Amlodipine Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Irbesartan Amlodipine Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Irbesartan Amlodipine Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Irbesartan Amlodipine Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Irbesartan Amlodipine Tablets Market Size by Country
    • 7.3.1 North America Irbesartan Amlodipine Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Irbesartan Amlodipine Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Irbesartan Amlodipine Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Irbesartan Amlodipine Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Irbesartan Amlodipine Tablets Market Size by Country
    • 8.3.1 Europe Irbesartan Amlodipine Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Irbesartan Amlodipine Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Irbesartan Amlodipine Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Irbesartan Amlodipine Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Irbesartan Amlodipine Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Irbesartan Amlodipine Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Irbesartan Amlodipine Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Irbesartan Amlodipine Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Irbesartan Amlodipine Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Irbesartan Amlodipine Tablets Market Size by Country
    • 10.3.1 South America Irbesartan Amlodipine Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Irbesartan Amlodipine Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Irbesartan Amlodipine Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Irbesartan Amlodipine Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Irbesartan Amlodipine Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Irbesartan Amlodipine Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Irbesartan Amlodipine Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Irbesartan Amlodipine Tablets Market Drivers
  • 12.2 Irbesartan Amlodipine Tablets Market Restraints
  • 12.3 Irbesartan Amlodipine Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Irbesartan Amlodipine Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Irbesartan Amlodipine Tablets
  • 13.3 Irbesartan Amlodipine Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Irbesartan Amlodipine Tablets Typical Distributors
  • 14.3 Irbesartan Amlodipine Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Irbesartan Amlodipine Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Irbesartan Amlodipine Tablets is a compound antihypertensive drug that combines two active ingredients: angiotensin II receptor antagonist irbesartan and calcium channel blocker amlodipine. Irbesartan blocks angiotensin II receptors to prevent vasoconstriction, thereby lowering blood pressure and reducing the burden on the heart and kidneys; amlodipine prevents calcium ions from entering the heart and vascular smooth muscle cells, leading to vasodilation and further lowering blood pressure.
    This report is a detailed and comprehensive analysis for global Irbesartan Amlodipine Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Irbesartan Amlodipine Tablets market size and forecasts, in consumption value ($ Million), sales quantity (g), and average selling prices (US$/g), 2021-2032
    Global Irbesartan Amlodipine Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (g), and average selling prices (US$/g), 2021-2032
    Global Irbesartan Amlodipine Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (g), and average selling prices (US$/g), 2021-2032
    Global Irbesartan Amlodipine Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (g), and ASP (US$/g), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Irbesartan Amlodipine Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Irbesartan Amlodipine Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Iluamix, Sanofi, Sumitomo Pharma, Teva Pharmaceutical, Novartis, Shionogi, Hanall, Shilpex Pharmysis, Garden Bio-chemical High-tech, Huahai Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Irbesartan Amlodipine Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Original Drug
    Generic Drug
    Market segment by Application
    Hypertension
    Myocardial infarction
    Others
    Major players covered
    Iluamix
    Sanofi
    Sumitomo Pharma
    Teva Pharmaceutical
    Novartis
    Shionogi
    Hanall
    Shilpex Pharmysis
    Garden Bio-chemical High-tech
    Huahai Pharmaceutical
    Shimei Pharmaceutica
    Kangzhe Pharmaceutica
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Irbesartan Amlodipine Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Irbesartan Amlodipine Tablets, with price, sales quantity, revenue, and global market share of Irbesartan Amlodipine Tablets from 2021 to 2026.
    Chapter 3, the Irbesartan Amlodipine Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Irbesartan Amlodipine Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Irbesartan Amlodipine Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Irbesartan Amlodipine Tablets.
    Chapter 14 and 15, to describe Irbesartan Amlodipine Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now